Women who go on to develop postpartum depression (PPD) may have characteristic levels of neuroactive steroids, molecules derived from the hormone progesterone, in their blood during the third trimester of pregnancy, according to a new study.
By teasing out the biological mechanisms underlying postpartum mental health disorders, investigators at Weill Cornell Medicine are laying the groundwork for new ways to detect and treat women at risk.
